Wei Ding

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

New approaches and procedures for cancer treatment: Current perspectives

BCL2 Suppresses PARP1 Function and Nonapoptotic Cell Death

Hypoxia Inducible Factor-1α Potentiates Jagged 1-Mediated Angiogenesis by Mesenchymal Stem Cell-Derived Exosomes

Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee

Cancer statistics, 2017

Biological functions of mesenchymal stem cells and clinical implications

Modulation of oxidative stress as an anticancer strategy

CD4 CD25 Foxp3 regulatory T cells and hematologic malignancies

Canonical and Noncanonical Hedgehog/GLI Signaling in Hematological Malignancies

CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity

Targeting B cell receptor signalling in cancer: preclinical and clinical advances

Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia

Inflammation and tumor progression: signaling pathways and targeted intervention

Aptamers as targeted therapeutics: current potential and challenges

Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases

Unraveling the therapeutic potential of the Hedgehog pathway in cancer

BCL-2 family isoforms in apoptosis and cancer

Understanding the Intersections between Metabolism and Cancer Biology

Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Exosomes

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States

The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization

Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box

How I treat autoimmune hemolytic anemias in adults

Macrophage plasticity and polarization in tissue repair and remodelling

CAR T cell immunotherapy for human cancer

Human FoxP3⁺CD4⁺ regulatory T cells: their knowns and unknowns

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

Prescribed drugs containing nitrogen heterocycles: an overview

The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells

Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis

Bi‐directional activation between mesenchymal stem cells and CLL B‐cells: implication for CLL disease progression

Chronic lymphocytic leukemia in young (<= 55 years) patients: a comprehensive analysis of prognostic factors and outcomes

Incidence of chronic lymphocytic leukemia and high‐count monoclonal B‐cell lymphocytosis using the 2008 guidelines

Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch

Impact of Ibrutinib and Idelalisib on the Pharmaceutical Cost of Treating Chronic Lymphocytic Leukemia at the Individual and Societal Levels

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre